PTPRC and neoplasm: In order to identify the transcriptional pathways regulating the T-PNU response in the tumor environment, we performed RNA-sequencing analysis of CD45+ tumor-derived cells from untreated control animals and tumor-bearing animals treated with trastuzumab, T-DM1 or T-PNU (Fig. 3a, see methods).